| Scrip Code | 544799 |
|---|---|
| NSE Symbol | TURTLEMINT |
| MSEI Symbol | NOTLISTED |
| ISIN | INE0OC301013 |
| Name of company | Turtlemint Fintech Solutions Limited |
| Type of company | Main Board |
| Class of security | Equity |
| Date of start of financial year | 01-04-2026 |
| Date of end of financial year | 31-03-2027 |
| Date of board meeting when results were approved | 12-11-2026 |
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 05-11-2026 |
| Description of presentation currency | INR |
| Level of rounding used in financial results | Lakhs |
| Reporting Type | Quarterly |
| Reporting Quarter | Second quarter |
| Nature of report standalone or consolidated | Consolidated |
| Whether results are audited or unaudited for the quarter ended | Unaudited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended | Unaudited |
| Segment Reporting | Single segment |
| Description of single segment | Financial products |
| Start date and time of board meeting | 12-11-2026 15:00:00 |
| End date and time of board meeting | 12-11-2026 16:02:00 |
| Whether cash flow statement is applicable on company | Yes |
| Type of cash flow statement | Cash Flow Indirect |
| Declaration of unmodified opinion or statement on impact of audit qualification | Not applicable |
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-07-2026 | 01-04-2026 |
| B | Date of end of reporting period | 30-09-2026 | 30-09-2026 |
| C | Whether results are audited or unaudited | Unaudited | Unaudited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| 1 | Income | ||
| Revenue from operations | 34,219.00 | 63,717.00 | |
| Other income | 947.00 | 1,104.00 | |
| Total income | 35,166.00 | 64,821.00 | |
| 2 | Expenses | ||
| (a) | Cost of materials consumed | 0.00 | 0.00 |
| (b) | Purchases of stock-in-trade | 0.00 | 0.00 |
| (c) | Changes in inventories of finished goods, work-in-progress and stock-in-trade | 0.00 | 0.00 |
| (d) | Employee benefit expense | 6,423.00 | 12,967.00 |
| (e) | Finance costs | 260.00 | 509.00 |
| (f) | Depreciation, depletion and amortisation expense | 430.00 | 830.00 |
| (f) | Other Expenses | ||
| 1 | Impairment losses on financial instruments | 241.00 | 257.00 |
| 2 | Other expenses | 30,167.00 | 56,400.00 |
| Total other expenses | 30,408.00 | 56,657.00 | |
| Total expenses | 37,521.00 | 70,963.00 | |
| 3 | Total profit before exceptional items and tax | (2,355.00) | (6,142.00) |
| 4 | Exceptional items | 0.00 | 0.00 |
| 5 | Total profit before tax | (2,355.00) | (6,142.00) |
| 6 | Tax expense | ||
| 7 | Current tax | 0.00 | 0.00 |
| 8 | Deferred tax | 228.00 | 219.00 |
| 9 | Total tax expenses | 228.00 | 219.00 |
| 10 | Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement | 0.00 | 0.00 |
| 11 | Net Profit Loss for the period from continuing operations | (2,583.00) | (6,361.00) |
| 12 | Profit (loss) from discontinued operations before tax | 0.00 | 0.00 |
| 13 | Tax expense of discontinued operations | 0.00 | 0.00 |
| 14 | Net profit (loss) from discontinued operation after tax | 0.00 | 0.00 |
| 15 | Share of profit (loss) of associates and joint ventures accounted for using equity method | 0.00 | 0.00 |
| 16 | Total profit (loss) for period | (2,583.00) | (6,361.00) |
| 17 | Other comprehensive income net of taxes | (35.00) | (72.00) |
| 18 | Total Comprehensive Income for the period | (2,618.00) | (6,433.00) |
| 19 | Total profit or loss, attributable to | ||
| Profit or loss, attributable to owners of parent | (2,583.00) | (6,361.00) | |
| Total profit or loss, attributable to non-controlling interests | 0.00 | 0.00 | |
| 20 | Total Comprehensive income for the period attributable to | ||
| Comprehensive income for the period attributable to owners of parent | (2,618.00) | (6,433.00) | |
| Total comprehensive income for the period attributable to owners of parent non-controlling interests | 0.00 | 0.00 | |
| 21 | Details of equity share capital | ||
| Paid-up equity share capital | 2,945.00 | 2,945.00 | |
| Face value of equity share capital | 1 | 1 | |
| 27 | Details of debt securities | ||
| 22 | Reserves excluding revaluation reserve | ||
| 23 | Earnings per share | ||
| i | Earnings per equity share for continuing operations | ||
| Basic earnings (loss) per share from continuing operations | -1 | -2.3 | |
| Diluted earnings (loss) per share from continuing operations | -1 | -2.3 | |
| ii | Earnings per equity share for discontinued operations | ||
| Basic earnings (loss) per share from discontinued operations | 0 | 0 | |
| Diluted earnings (loss) per share from discontinued operations | 0 | 0 | |
| ii | Earnings per equity share | ||
| Basic earnings (loss) per share from continuing and discontinued operations | -1 | -2.3 | |
| Diluted earnings (loss) per share from continuing and discontinued operations | -1 | -2.3 | |
| 24 | Debt equity ratio | ||
| 25 | Debt service coverage ratio | ||
| 26 | Interest service coverage ratio | ||
| 27 | Disclosure of notes on financial results | Textual Information(1) | |
| Textual Information(1) | 1. Turtlemint Fintech Solutions Limited (the ‘Company’) has prepared Unaudited Consolidated Financial Results (the 'Statement') for the quarter and half year ended September 30, 2026 in accordance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended (the ‘Listing Regulations, 2015’) and the Accounting Standards specified under section 133 of the Companies Act, 2013 read with the Companies (‘Indian Accounting Standards’ / ‘IND AS’) Rules, 2015 as amended and the relevant provisions of the Companies Act, 2013, as applicable. 2. The Unaudited Consolidated Financial Results of the Company and its subsidiaries (together referred to as ‘Group’), for the quarter and half year ended September 30, 2026 have been reviewed by the Audit Committee and approved by the Board of Directors at their meetings held on November 12, 2026 . Following is the list of subsidiaries forming part of Unaudited Consolidated Financial Results: (i) Turtlemint Insurance Broking Services Private Limited (TIB) (ii) Turtlemint Mutual Funds Distributors Private Limited (TMF) 3. These Unaudited Consolidated Financial Results for the quarter and half year ended September 30, 2026 have been subjected to limited review by the Statutory Auditors of the Company. 4. The figures for the quarter ended September 30, 2026 are the balancing figures between the unaudited figures for the half year ended September 30, 2026 and unaudited figures for the quarter ended June 30, 2026. The figures for the quarter ended September 30, 2025 are the balancing figures between the audited figures for the half year ended September 30, 2025 and unaudited figures for the quarter ended June 30, 2025. 5. The Company has completed Initial Public Offer (IPO) of 5,80,70,398 equity shares of face value of INR 1 each at an issue price of INR 152 per share, comprising of fresh issue of 4,34,68,552 shares, issued at an offer price of INR 152 per equity share to all the allottees amounting to INR 660.72 crore and offer for sale of 1,46,01,846 equity shares by the selling shareholders aggregating to INR 221.95 crore. Pursuant to the IPO, the equity shares of the Company were listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) on June 29 ,2026. Consequently, the paid-up equity share capital of the Company increased from INR 25.10 crore before IPO to INR 29.45 crore comprising 29,44,78,906 fully paid-up equity shares of INR 1 each. The utilisation of gross proceeds is as follows: a. Expenditure towards cloud and server related infrastructure of our Company - Amount to be utilised as per Prospectus is INR 25.64 crore Amount utilised upto September 30, 2026 is INR 2.57 crore Total amount unutilised as on September 30, 2026 is INR 23.07 crore b. Salary expenditure towards the technology and product development teams of our Company - Amount to be utilised as per Prospectus is INR 193.04 crore Amount utilised upto September 30, 2026 is INR 6.55 crore Total amount unutilised as on September 30, 2026 is INR 186.49 crore c. Expenditure towards marketing initiatives by our Company - Amount to be utilised as per Prospectus is INR 39.07 crore Amount utilised upto September 30, 2026 is INR 3.18 crore Total amount unutilised as on September 30, 2026 is INR 35.89 crore d. Expenditure towards lease payments for existing properties of our Company and our wholly owned Subsidiary, TIB- (i) Expense by our company - Amount to be utilised as per Prospectus is INR 22.21 crore Amount utilised upto September 30, 2026 is INR 1.32 crore Total amount unutilised as on September 30, 2026 is INR 20.89 crore (ii) Expense by our wholly owned Subsidiary, TIB - Amount to be utilised as per Prospectus is INR 20.87 crore Amount utilised upto September 30, 2026 is INR Nil Total amount unutilised as on September 30, 2026 is INR 20.87 crore e. Investment in our wholly owned Subsidiary, TIB, for funding its working capital requirements - Amount to be utilised as per Prospectus is INR 128.64 crore Amount utilised upto September 30, 2026 is INR Nil Total amount unutilised as on September 30, 2026 is INR 128.64 crore f. Funding inorganic growth through unidentified acquisitions and strategic initiatives and general corporate purposes - Amount to be utilised as per Prospectus is INR 151.24 crore Amount utilised upto September 30, 2026 is INR Nil Total amount unutilised as on September 30, 2026 is INR 151.24 crore g. Estimated Offer expenses to the extent applicable to the Fresh Issue (only those apportioned to our Company)- Amount to be utilised as per Prospectus is INR 80.01 crore Amount utilised upto September 30, 2026 is INR 5.63 crore Total amount unutilised as on September 30, 2026 is INR 74.38 crore 6. Exceptional items - includes following - (i) The Company has incurred costs in connection with its Initial Public Offering (“IPO”) and has accounted for such costs in accordance with Ind AS 32, Financial Instruments: Presentation. Accordingly, IPO-related costs that are incremental and directly attributable to the issue of new equity shares have been adjusted against the securities premium balance, while costs attributable to the offer for sale are recoverable from the selling shareholders. Costs that do not meet this criteria have been charged to the Statement of Profit and Loss. IPO-related costs amounting to INR 2.41 crore have been recognised as Exceptional Items for the quarter and half year ended September 30, 2025 and year-ended March 31, 2026, as these expenses are non-recurring in nature and do not arise from the Company’s ordinary operating activities. Further, certain IPO-related costs amounting to INR Nil as at September 30, 2026 (INR 20.18 crore as at March 31, 2026) which are directly attributable to the issuance of equity instruments under IPO, have been disclosed in Other Current Assets under Prepaid Expenses. The Company has incurred INR 60.88 crore (net of exceptional items) as IPO related expenses and allocated such expenses between the Company (INR 45.57 crore) and selling shareholders (INR 15.31 crore) in proportion to the equity shares allotted to the public as fresh issue by the Company and under offer for sale by selling shareholders respectively. The Company's share in the IPO-related costs which are incremental and directly attributable i.e. INR 45.57 crore have been adjusted against securities premium balance. (ii)The Board of Directors of the Company at its meeting held on July 12, 2025 and Shareholders of the Company in their extraordinary general meeting held on July 17, 2025, approved a bonus issue of 500 equity shares for every equity share held by the equity shareholders of the Company as of July 12, 2025. Accordingly, the Board of Directors of the Company has, pursuant to the resolution dated July 21, 2025, made an allotment of 5,26,36,000 bonus equity shares of INR. 1/- each to its equity shareholders utilising securities premium account balance. Consequent to the bonus issue to the equity shareholders, the Board of Directors at its meeting held on August 12, 2025 and Shareholders of the Company in their extraordinary general meeting held on August 14, 2025, approved to adjust the conversion ratio of Seed Round CCPS, Series A CCPS, Series B CCPS, Series C CCPS, Series C1 CCPS, Series C2 CCPS, Series D CCPS, Series D1 CCPS, Series D2 CCPS and Series E CCPS to give an impact of the bonus issue referred above. Furthermore, the shareholders of the Company entered into the first amendment to the Series E amended and restated shareholders’ agreement ('the agreement') wherein the conversion ratio were agreed to be modified and adjusted downwards to 477:1 on the filing of the Pre-filled Draft Red Herring Prospectus (PDRHP) and further changed pursuant to the Board resolution dated May 28, 2026 approving the draft filing of Updated Draft Red Herring Prospectus-II (UDRHP-II). Consequently, the conversion ratio was revised to 463:1 for Seed Round CCPS, Series A CCPS, Series B CCPS, Series C CCPS, Series D CCPS, Series D1 CCPS, Series D2 CCPS and Series E CCPS, 622.5437:1 for Series C1 CCPS and 511.5499:1 for Series C2 CCPS. The approval of UDRHP-II and the revised conversion ratio resulted in an increase in the shareholding of the existing equity shareholders of the Company. Such increase was recognised under Exceptional Items amounting to INR 31.57 crore in the unaudited consolidated financial results for the quarter ended September 30, 2025 and the audited consolidated financial results for the half year ended September 30, 2025, and INR 52.52 crore in the audited consolidated financial results for the year ended March 31, 2026. Subsequently, pursuant to the Board resolution dated May 28, 2026, all CCPS holders converted their CCPS into equity shares at the aforesaid agreed conversion ratio. 7. As a consequence of the transaction described in Note 6(ii), the number of shares used for the calculation of basic and diluted earnings per share, have been adjusted pursuant to Paragraph 64 of Ind AS 33 - Earnings Per Share, prescribed under Section 133 of the Companies Act, 2013 for the quarter and half year ended September 30, 2025 and year ended March 31, 2026. 8. Earnings per share for the quarter and half year ended are not annualised. 9. Pursuant to the Board resolution dated March 26, 2026, the Company received an amount of INR 50 crore from Trifecta Venture Debt Fund - III and Trifecta Venture Debt Fund - IV towards the issuance of 13.75% Non-Convertible Debentures (NCDs). Interest on the NCDs is payable at the end of each month, along with an additional coupon payment at the rate of 0.60% on the debenture subscription amount (i.e., the amount of funds raised through the debentures) at the end of each quarter. The NCDs carry an initial principal moratorium period of eight months and are repayable within 36 months from the date of issuance. The NCDs are secured by a first charge over all the present and future assets of the Company and its subsidiary, Turtlemint Mutual Funds Distributors Private Limited, and a second charge over all the present and future assets of its subsidiary, Turtlemint Insurance Broking Services Private Limited. 10. No stock options were granted during the quarter and half year ended September 30, 2026. 11. The Company allotted 12,33,880 Equity Shares on April 16, 2026 to the eligible Employees pursuant to the exercise of options under the approved employee stock option schemes. 12. The Chief Operating Decision Maker (CODM) monitors the operating results of the Group as a whole for the purpose of making decisions about resource allocation and performance assessment. The Group is engaged in the business of providing insurance broking services, technical support and information and technology services. Thus in context of Ind AS 108, Operating Segments, the Group's operations are considered to constitute a single operating segment and there are no separate geographical segments. 13. Effective from the quarter ended June 30, 2026, all comparative figures have been restated from INR million to INR crore, rounded off to the nearest INR crore, to maintain consistency in presentation, any minor variances arising from this change are solely attributable to rounding adjustments. Further, amounts which are less than half a lakh are appearing as ^. 14. All amounts disclosed in the Unaudited Consolidated Financial Results have been rounded off to the nearest crore, except earnings per share and where otherwise stated. 15.Figures for the previous quarters and year have been regrouped/reclassed wherever necessary, to correspond with the current period's classifications and disclosures. 16. These Unaudited Consolidated Financial Results are available on the website of BSE Limited ('BSE') (www.bseindia.com), National Stock Exchange of India Limited ('NSE') (www.nseindia.com) and Company's website (www.turtlemint.com). |
|---|
| Debt equity ratio | |
|---|---|
| Debt service coverage ratio | |
| Interest service coverage ratio |
| Particulars | Year ended (dd-mm-yyyy) | |
|---|---|---|
| Date of start of reporting period | 01-04-2026 | |
| Date of end of reporting period | 30-09-2026 | |
| Whether results are audited or unaudited | Unaudited | |
| Nature of report standalone or consolidated | Consolidated | |
| Assets | ||
| 1 | Non-current assets | |
| Property, plant and equipment | 2,374.00 | |
| Capital work-in-progress | ||
| Investment property | ||
| Goodwill | 910.00 | |
| Other intangible assets | 219.00 | |
| Intangible assets under development | ||
| Biological assets other than bearer plants | ||
| Investments accounted for using equity method | ||
| Non-current financial assets | ||
| Non-current investments | 0.00 | |
| Trade receivables, non-current | ||
| Loans, non-current | 0.00 | |
| Other non-current financial assets | ||
| 1 | Other financial assets | 330.00 |
| Total of other non-current financial assets | 330.00 | |
| Total non-current financial assets | 330.00 | |
| Deferred tax assets (net) | 649.00 | |
| Other non-current assets | ||
| 1 | Income tax assets (net) | 7,131.00 |
| 2 | Other non-current assets | 29.00 |
| Total of other non-current assets | 7,160.00 | |
| Total non-current assets | 11,642.00 | |
| 2 | Current assets | |
| Inventories | 0.00 | |
| Current financial asset | ||
| Current investments | 0.00 | |
| Trade receivables, current | 17,379.00 | |
| Cash and cash equivalents | 38,076.00 | |
| Bank balance other than cash and cash equivalents | 35,365.00 | |
| Loans, current | 0.00 | |
| Other current financial assets | ||
| Total of other current financial assets | 462.00 | |
| Total current financial assets | 91,282.00 | |
| Current tax assets (net) | ||
| Other current assets | ||
| 1 | Other current assets | 4,534.00 |
| Total of other current assets | 4,534.00 | |
| Total current assets | 95,816.00 | |
| 3 | Non-current assets classified as held for sale | |
| 4 | Regulatory deferral account debit balances and related deferred tax Assets | |
| Total assets | 1,07,458.00 | |
| Equity and liabilities | ||
| 1 | Equity | |
| Equity attributable to owners of parent | ||
| Equity share capital | 2,945.00 | |
| Other equity | 83,813.00 | |
| Total equity attributable to owners of parent | 86,758.00 | |
| Non controlling interest | ||
| Total equity | 86,758.00 | |
| 2 | Liabilities | |
| Non-current liabilities | ||
| Non-current financial liabilities | ||
| Borrowings, non-current | 3,272.00 | |
| Trade payables, non-current | ||
| (A) Total outstanding dues of micro enterprises and small enterprises | ||
| (B) Total outstanding dues of creditors other than micro enterprises and small enterprises | ||
| Total Trade payable | ||
| Other non-current financial liabilities | ||
| 1 | Lease liabilities | 737.00 |
| Total of other non-current financial liabilities | 737.00 | |
| Total non-current financial liabilities | 4,009.00 | |
| Provisions, non-current | 1,560.00 | |
| Deferred tax liabilities (net) | ||
| Deferred government grants, Non-current | ||
| Other non-current liabilities | ||
| Total of other non-current liabilities | ||
| Total non-current liabilities | 5,569.00 | |
| Current liabilities | ||
| Current financial liabilities | ||
| Borrowings, current | 1,718.00 | |
| Trade payables, current | ||
| (A) Total outstanding dues of micro enterprises and small enterprises | 560.00 | |
| (B) Total outstanding dues of creditors other than micro enterprises and small enterprises | 7,638.00 | |
| Total Trade payable | 8,198.00 | |
| Other current financial liabilities | ||
| 1 | Lease liabilities | 985.00 |
| 2 | Other financial liabilities | 1,520.00 |
| Total of other current financial liabilities | 2,505.00 | |
| Total current financial liabilities | 12,421.00 | |
| Other current liabilities | 2,219.00 | |
| 1 | Other current liabilities | 2,219.00 |
| Total of other current liabilities | 2,219.00 | |
| Provisions, current | 491.00 | |
| Current tax liabilities (Net) | ||
| Deferred government grants, Current | ||
| Total current liabilities | 15,131.00 | |
| 3 | Liabilities directly associated with assets in disposal group classified as held for sale | |
| 4 | Regulatory deferral account credit balances and related deferred tax liability | |
| Total liabilities | 20,700.00 | |
| Total equity and liabilites | 1,07,458.00 | |
| Disclosure of notes on assets and liabilities | ||
| Particulars | 3 months/ 6 month ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |||||
|---|---|---|---|---|---|---|---|
| Date of start of reporting period | 01-07-2026 | 01-04-2026 | |||||
| Date of end of reporting period | 30-09-2026 | 30-09-2026 | |||||
| Whether results are audited or unaudited | Unaudited | Unaudited | |||||
| Nature of report standalone or consolidated | Consolidated | Consolidated | |||||
| 1 | Segment Revenue (Income) | ||||||
| (net sale/income from each segment should be disclosed) | |||||||
| Total Segment Revenue | |||||||
| Less: Inter segment revenue | |||||||
| Revenue from operations | |||||||
| 2 | Segment Result | ||||||
| Profit (+) / Loss (-) before tax and interest from each segment | |||||||
| Total Profit before tax | |||||||
| i. Finance cost | |||||||
| ii. Other Unallocable Expenditure net off Unallocable income | |||||||
| Profit before tax | |||||||
| 3 | (Segment Asset - Segment Liabilities) | ||||||
| Segment Asset | |||||||
| Total Segment Asset | |||||||
| Un-allocable Assets | null | null | |||||
| Net Segment Asset | null | null | |||||
| 4 | Segment Liabilities | ||||||
| Segment Liabilities | |||||||
| Total Segment Liabilities | |||||||
| Un-allocable Liabilities | null | null | |||||
| Net Segment Liabilities | null | null | |||||
| Disclosure of notes on segments | |||||||
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-07-2026 | 01-04-2026 |
| B | Date of end of reporting period | 30-09-2026 | 30-09-2026 |
| C | Whether results are audited or unaudited | Unaudited | Unaudited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| Other comprehensive income [Abstract] | |||
| 1 | Amount of items that will not be reclassified to profit and loss | ||
| 1 | Remeasurements of gains/(losses) of defined benefit plans | (35.00) | (81.00) |
| Total Amount of items that will not be reclassified to profit and loss | (35.00) | (81.00) | |
| 2 | Income tax relating to items that will not be reclassified to profit or loss | 0.00 | (9.00) |
| 3 | Amount of items that will be reclassified to profit and loss | ||
| Total Amount of items that will be reclassified to profit and loss | |||
| 4 | Income tax relating to items that will be reclassified to profit or loss | ||
| 5 | Total Other comprehensive income | (35.00) | (72.00) |
| Particulars | Year ended (dd-mm-yyyy) | |||||
|---|---|---|---|---|---|---|
| A | Date of start of reporting period | 01-04-2026 | ||||
| B | Date of end of reporting period | 30-09-2026 | ||||
| C | Whether results are audited or unaudited | Unaudited | ||||
| D | Nature of report standalone or consolidated | Consolidated | ||||
| Statement of cash flows | ||||||
| Cash flows from used in operating activities | ||||||
| Profit before tax | (6,142.00) | |||||
| Adjustments for reconcile profit (loss) | ||||||
| Adjustments for finance costs | 509.00 | |||||
| Adjustments for decrease (increase) in inventories | 0.00 | |||||
| Adjustments for decrease (increase) in trade receivables, current | (1,719.00) | |||||
| Adjustments for decrease (increase) in trade receivables, non-current | 0.00 | |||||
| Adjustments for decrease (increase) in other current assets | (920.00) | |||||
| Adjustments for decrease (increase) in other non-current assets | (21.00) | |||||
| Adjustments for other financial assets, non-current | 247.00 | |||||
| Adjustments for other financial assets, current | (524.00) | |||||
| Adjustments for other bank balances | 0.00 | |||||
| Adjustments for increase (decrease) in trade payables, current | (568.00) | |||||
| Adjustments for increase (decrease) in trade payables, non-current | 0.00 | |||||
| Adjustments for increase (decrease) in other current liabilities | (440.00) | |||||
| Adjustments for increase (decrease) in other non-current liabilities | 0.00 | |||||
| Adjustments for depreciation and amortisation expense | 830.00 | |||||
| Adjustments for impairment loss reversal of impairment loss recognised in profit or loss | 257.00 | |||||
| Adjustments for provisions, current | 23.00 | |||||
| Adjustments for provisions, non-current | 318.00 | |||||
| Adjustments for other financial liabilities, current | 290.00 | |||||
| Adjustments for other financial liabilities, non-current | 0.00 | |||||
| Adjustments for unrealised foreign exchange losses gains | 0.00 | |||||
| Adjustments for dividend income | 0.00 | |||||
| Adjustments for interest income | 1,076.00 | |||||
| Adjustments for share-based payments | 1,155.00 | |||||
| Adjustments for fair value losses (gains) | 0.00 | |||||
| Adjustments for undistributed profits of associates | 0.00 | |||||
| Other adjustments for which cash effects are investing or financing cash flow | 9.00 | |||||
| Other adjustments to reconcile profit (loss) | 0.00 | |||||
| Other adjustments for non-cash items | 0.00 | |||||
| Share of profit and loss from partnership firm or association of persons or limited liability partnerships | 0.00 | |||||
| Total adjustments for reconcile profit (loss) | (1,630.00) | |||||
| Net cash flows from (used in) operations | (7,772.00) | |||||
| Dividends received | 0.00 | |||||
| Interest paid | 0.00 | |||||
| Interest received | 0.00 | |||||
| Income taxes paid (refund) | 1,195.00 | |||||
| Other inflows (outflows) of cash | 0.00 | |||||
| Net cash flows from (used in) operating activities | (8,967.00) | |||||
| Cash flows from used in investing activities | ||||||
| Cash flows from losing control of subsidiaries or other businesses | 0.00 | |||||
| Cash flows used in obtaining control of subsidiaries or other businesses | 0.00 | |||||
| Other cash receipts from sales of equity or debt instruments of other entities | 0.00 | |||||
| Other cash payments to acquire equity or debt instruments of other entities | 0.00 | |||||
| Other cash receipts from sales of interests in joint ventures | 0.00 | |||||
| Other cash payments to acquire interests in joint ventures | 0.00 | |||||
| Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships | 0.00 | |||||
| Cash payment for investment in partnership firm or association of persons or limited liability partnerships | 0.00 | |||||
| Proceeds from sales of property, plant and equipment | 0.00 | |||||
| Purchase of property, plant and equipment | 445.00 | |||||
| Proceeds from sales of investment property | 1.00 | |||||
| Purchase of investment property | 0.00 | |||||
| Proceeds from sales of intangible assets | 0.00 | |||||
| Purchase of intangible assets | 0.00 | |||||
| Proceeds from sales of intangible assets under development | 0.00 | |||||
| Purchase of intangible assets under development | 0.00 | |||||
| Proceeds from sales of goodwill | 0.00 | |||||
| Purchase of goodwill | 0.00 | |||||
| Proceeds from biological assets other than bearer plants | 0.00 | |||||
| Purchase of biological assets other than bearer plants | 0.00 | |||||
| Proceeds from government grants | 0.00 | |||||
| Proceeds from sales of other long-term assets | 0.00 | |||||
| Purchase of other long-term assets | 0.00 | |||||
| Cash advances and loans made to other parties | 0.00 | |||||
| Cash receipts from repayment of advances and loans made to other parties | 0.00 | |||||
| Cash payments for future contracts, forward contracts, option contracts and swap contracts | 0.00 | |||||
| Cash receipts from future contracts, forward contracts, option contracts and swap contracts | 0.00 | |||||
| Dividends received | 0.00 | |||||
| Interest received | 580.00 | |||||
| Income taxes paid (refund) | 0.00 | |||||
| Other inflows (outflows) of cash | (28,959.00) | |||||
| Net cash flows from (used in) investing activities | (28,823.00) | |||||
| Cash flows from used in financing activities | ||||||
| Proceeds from changes in ownership interests in subsidiaries | 0.00 | |||||
| Payments from changes in ownership interests in subsidiaries | 0.00 | |||||
| Proceeds from issuing shares | 66,072.00 | |||||
| Proceeds from issuing other equity instruments | 0.00 | |||||
| Payments to acquire or redeem entity's shares | 0.00 | |||||
| Payments of other equity instruments | 0.00 | |||||
| Proceeds from exercise of stock options | 0.00 | |||||
| Proceeds from issuing debentures notes bonds etc | 0.00 | |||||
| Proceeds from borrowings | 4,950.00 | |||||
| Repayments of borrowings | 0.00 | |||||
| Payments of lease liabilities | 640.00 | |||||
| Dividends paid | 0.00 | |||||
| Interest paid | 469.00 | |||||
| Income taxes paid (refund) | 0.00 | |||||
| Other inflows (outflows) of cash | (868.00) | |||||
| Net cash flows from (used in) financing activities | 69,045.00 | |||||
| Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes | 31,255.00 | |||||
| Effect of exchange rate changes on cash and cash equivalents | ||||||
| Effect of exchange rate changes on cash and cash equivalents | 0.00 | |||||
| Net increase (decrease) in cash and cash equivalents | 31,255.00 | |||||
| Cash and cash equivalents cash flow statement at beginning of period | 6,821.00 | |||||
| Cash and cash equivalents cash flow statement at end of period | 38,076.00 | |||||